YS Biopharma Co., Ltd. (YS)

NASDAQ: YS · IEX Real-Time Price · USD
1.51
+0.01 (0.67%)
May 31, 2023, 4:00 PM EDT - Market closed

Income Statement (Annual)

Millions CNY. Fiscal year is Apr - Mar.
Year 20212020
Revenue
502.95257.02
Revenue Growth (YoY)
95.69%-
Cost of Revenue
117.0759.66
Gross Profit
385.88197.36
Selling, General & Admin
293.62228.82
Research & Development
211.2294.39
Operating Expenses
504.84323.21
Operating Income
-118.96-125.85
Interest Expense / Income
2.7229.69
Other Expense / Income
-20.6118.83
Pretax Income
-101.07-174.37
Income Tax
4.9417.45
Net Income
-106-191.83
Preferred Dividends
130.6616.61
Net Income Common
-236.67-208.44
Shares Outstanding (Basic)
247247
Shares Outstanding (Diluted)
247247
EPS (Basic)
-0.43-0.78
EPS (Diluted)
-0.43-0.78
Free Cash Flow Per Share
-1.90-1.42
Gross Margin
76.72%76.79%
Operating Margin
-23.65%-48.96%
Profit Margin
-47.06%-81.10%
Free Cash Flow Margin
-93.22%-136.51%
EBITDA
-63.41-114.54
EBITDA Margin
-12.61%-44.57%
Depreciation & Amortization
34.9430.14
EBIT
-98.35-144.68
EBIT Margin
-19.55%-56.29%
Source: Financials are provided by Nasdaq Data Link and sourced from audited reports submitted to the Securities and Exchange Commission (SEC).